<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T08:38:40Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/11597" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/11597</identifier><datestamp>2026-09-24T01:26:48Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Inman, Mark D</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Janssen, Luke</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Jordana, Manel</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Dalle, Ave J Christopher</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences (Division of Physiology/Pharmacology)</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T16:55:30Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T16:55:30Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2011-11-11</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2012-04</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/6554</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">7523</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">2345943</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/11597</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/9383</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>&lt;strong>Introduction&lt;/strong>&lt;/p> &lt;p>The airway epithelium, which acts as a protective barrier, is impaired in asthmatic patients and may contribute to abnormal airway function. Chronic inflammation, a feature of asthma, is associated with structural changes in the airway epithelium including the transformation of columnar epithelial cells into mucin secreting goblet cells. Human epithelial cells exposed to Interleukin-13 (IL-13) &lt;em>in vitro&lt;/em> resulted in goblet cell metaplasia and a significant drop in transepithelial resistance, indicating that barrier function is impaired.&lt;/p> &lt;p>&lt;strong>Aim&lt;/strong>&lt;/p> &lt;p>We sought to determine whether goblet cell metaplasia alone is sufficient to impair airway epithelial barrier function &lt;em>in vivo&lt;/em>.&lt;/p> &lt;p>&lt;strong>Methods&lt;/strong>&lt;/p> &lt;p>Female BALB/c mice were infected with an adenovirus to overexpress IL-13, a control adenovirus, or no virus. Barrier integrity was assessed via single-photon emission computed tomography (SPECT) imaging by measuring the dispersion of technetium-labeled diethylene triamine pentaacetic acid (&lt;sup>99m&lt;/sup>Tc-DTPA) out of the lungs over time. Lung sections were stained by Periodic acid-Schiff to detect the presence of mucin-containing goblet cells.&lt;/p> &lt;p>&lt;strong>Results&lt;/strong>&lt;/p> &lt;p>IL-13 exposure resulted in goblet cell metaplasia and associated airway hyperresponsiveness to methacholine. However, there was no significant increase in dispersion of &lt;sup>99m&lt;/sup>Tc-DTPA over time from the airways in IL-13 overexpressed mice compared to control mice.&lt;/p> &lt;p>&lt;strong>Conclusion&lt;/strong>&lt;/p> &lt;p>IL-13 induced goblet cell metaplasia did not impair the airway epithelial barrier to &lt;sup>99m&lt;/sup>Tc-DTPA in our &lt;em>in vivo&lt;/em> mouse model. Therefore, we conclude that epithelial dysfunction to DTPA observed in human asthmatics and in animal models of asthma are not due to IL-13 induced goblet cell metaplasia.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">epithelial barrier</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">IL-13</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">asthma</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biological Phenomena, Cell Phenomena, and Immunity</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Circulatory and Respiratory Physiology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biological Phenomena, Cell Phenomena, and Immunity</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">The Effect of Goblet Cell Metaplasia On Airway Barrier Integrity</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>